Cell Therapeutics, Inc. (NASDAQ: CTIC) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and  These institutions hold a total of 65,670,333 shares. Largest shareholders include Bvf Inc/il, Orbimed Advisors Llc, Stonepine Capital Management, LLC, NEA 

These institutions hold a total of 65,670,333 shares. Largest shareholders include Bvf Inc/il, Orbimed Advisors Llc, Stonepine Capital Management, LLC, NEA  (LCTX) CEO Brian Culley on Q4 2019 Results - Earnings Call Transcript. 25 days ago - Seeking Alpha - Healthcare. Summary. Lineage Cell Therapeutics, Inc. (  CTIC stock rating and analysis - CTI BioPharmarp : a summary of key financial strength and profitability metrics. Earnings Yield (Greenblatt) %, -90.04  Get today's CTi Biopharma Corp stock price and latest CTIC news as well as CTi stocks were mixed after the close on Wednesday, as gains in the Financials,  Stock analysis for CTI BioPharma Corp (CTIC:NASDAQ CM) including stock price , stock chart Earnings Announcement for Period Ending Q1/2020:05/01/2020  Aug 1, 2019 In August 2017, we invested $25 million for preferred shares of Eventbrite, earnings. Net loss in the second quarter of 2019 was $7 million  Mar 12, 2020 (Nasdaq: CTIC) today reported its financial results for the fourth Quarterly Report on Form 10-Q for the quarter ended September 30, 2019.

CTIC: Get the latest CTI BioPharma stock price and detailed information including CTIC news, EARNINGS SUMMARY: Details of CTI BioPharma Corp.

(CTIC) stock price, news, historical charts, analyst ratings and financial information from CTIC (U.S.: Nasdaq) Per-Share Earnings, Actuals and Estimates. 1 Year % Chg -9.19. Market Cap 70.7M. Shares Outstanding 73.7M. Beta 1.58. Dividend (Yield) -. Div Amount -. Ex Div Date -. Earnings Date 2020-05-03. How do you think NASDAQ:CTIC will perform against the market? Paclitaxel analogue Opaxio wasn't mentioned in the last earnings PR, although a phase III  CTIC: Get the latest CTI BioPharma stock price and detailed information including CTIC news, EARNINGS SUMMARY: Details of CTI BioPharma Corp. (Nasdaq: CTIC) (“CTI” or “the Company”) today announced the outcome of a Type B, End-of-Phase-2a meeting with the U.S. Food and Drug Administration  Cell Therapeutics, Inc. (NASDAQ: CTIC) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and 

Aug 1, 2019 In August 2017, we invested $25 million for preferred shares of Eventbrite, earnings. Net loss in the second quarter of 2019 was $7 million 

CTIC stock rating and analysis - CTI BioPharmarp : a summary of key financial strength and profitability metrics. Earnings Yield (Greenblatt) %, -90.04  Get today's CTi Biopharma Corp stock price and latest CTIC news as well as CTi stocks were mixed after the close on Wednesday, as gains in the Financials,  Stock analysis for CTI BioPharma Corp (CTIC:NASDAQ CM) including stock price , stock chart Earnings Announcement for Period Ending Q1/2020:05/01/2020 

How do you think NASDAQ:CTIC will perform against the market? Paclitaxel analogue Opaxio wasn't mentioned in the last earnings PR, although a phase III 

Cell Therapeutics, Inc. (NASDAQ: CTIC) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and  These institutions hold a total of 65,670,333 shares. Largest shareholders include Bvf Inc/il, Orbimed Advisors Llc, Stonepine Capital Management, LLC, NEA  (LCTX) CEO Brian Culley on Q4 2019 Results - Earnings Call Transcript. 25 days ago - Seeking Alpha - Healthcare. Summary. Lineage Cell Therapeutics, Inc. (  CTIC stock rating and analysis - CTI BioPharmarp : a summary of key financial strength and profitability metrics. Earnings Yield (Greenblatt) %, -90.04  Get today's CTi Biopharma Corp stock price and latest CTIC news as well as CTi stocks were mixed after the close on Wednesday, as gains in the Financials,  Stock analysis for CTI BioPharma Corp (CTIC:NASDAQ CM) including stock price , stock chart Earnings Announcement for Period Ending Q1/2020:05/01/2020  Aug 1, 2019 In August 2017, we invested $25 million for preferred shares of Eventbrite, earnings. Net loss in the second quarter of 2019 was $7 million 

Find the latest and the upcoming CTI BioPharma earnings report Mar 23, 2020 as well as EPS Forecast and CTIC top analyst price target The TipRanks Smart Score analyzes stocks based on 8 factors extracted from our unique datasets.

View CTI BioPharma's (NASDAQ:CTIC) earnings history, next earnings date and earnings MarketBeat - Stock Market News and Research Tools logo. Sign up Mar 3, 2020 CTI BioPharma Corp. (CTIC) latest earnings report: revenue, EPS, surprise, history, news and analysis. Find the latest and the upcoming CTI BioPharma earnings report Mar 23, 2020 as well as EPS Forecast and CTIC top analyst price target The TipRanks Smart Score analyzes stocks based on 8 factors extracted from our unique datasets. (CTIC) stock quote, history, news and other vital information to help you with your stock trading and investing. Earnings Date, Mar 12, 2020. Forward Dividend  N/A, EPS Growth Rate, N/A. Average EPS % Beat Rate, -13.4%, Revenue Growth Rate, N/A. Average % Move 1-Wk after EPS, -25.7%, Normal Earnings Time 

Find the latest Earnings Report Date for CTI BioPharma Corp. (DE) Common Stock (CTIC) at Nasdaq.com. View CTI BioPharma's (NASDAQ:CTIC) earnings history, next earnings date and earnings MarketBeat - Stock Market News and Research Tools logo. Sign up Mar 3, 2020 CTI BioPharma Corp. (CTIC) latest earnings report: revenue, EPS, surprise, history, news and analysis. Find the latest and the upcoming CTI BioPharma earnings report Mar 23, 2020 as well as EPS Forecast and CTIC top analyst price target The TipRanks Smart Score analyzes stocks based on 8 factors extracted from our unique datasets. (CTIC) stock quote, history, news and other vital information to help you with your stock trading and investing. Earnings Date, Mar 12, 2020. Forward Dividend